Literature DB >> 2488180

Peritoneal surface-active material in continuous ambulatory peritoneal dialysis (CAPD) patients.

C Ziegler1, M Torchia, G R Grahame, I A Ferguson.   

Abstract

Phospholipids have been demonstrated to be present in the peritoneal dialysis effluent of 34 patients on continuous ambulatory peritoneal dialysis (CAPD). The phospholipids present have been characterized by chromatography and their relative concentrations are fairly consistent from patient to patient. The predominant phospholipid is phosphatidylcholine (81%). Surface activity of this phospholipid has been demonstrated. The concentration of total phospholipid correlates with the time the patient had been on CAPD. It is lower in those patients who have been on dialysis longer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2488180

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  4 in total

1.  Pleural pressure theory revisited: a role for capillary equilibrium.

Authors:  Aaron R Casha; Roberto Caruana-Gauci; Alexander Manche; Marilyn Gauci; Stanley Chetcuti; Luca Bertolaccini; Marco Scarci
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  Expression of hydrophilic surfactant proteins by mesentery cells in rat and man.

Authors:  B Chailley-Heu; S Rubio; J P Rougier; R Ducroc; A M Barlier-Mur; P Ronco; J R Bourbon
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

3.  Increased storage and secretion of phosphatidylcholines by senescent human peritoneal mesothelial cells.

Authors:  Maria Bartosova; Andras Rudolf; Sebastian Pichl; Kathrin Schmidt; Jürgen G Okun; Beate K Straub; Rafael Rutkowski; Janusz Witowski; Claus P Schmitt
Journal:  Clin Exp Nephrol       Date:  2015-11-02       Impact factor: 2.801

Review 4.  Surface tension in human pathophysiology and its application as a medical diagnostic tool.

Authors:  Anahita Fathi-Azarbayjani; Abolghasem Jouyban
Journal:  Bioimpacts       Date:  2015-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.